TheraRadar
← Back
Data updated: Mar 29, 2026

PRASCO

OncologyRespiratoryDermatology
Generics

PRASCO is a generic drug manufacturer focused on Oncology, Respiratory, Dermatology.

1971
Since
6
Drugs
-
Trials
125
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

SULFAMETHOXAZOLE AND TRIMETHOPRIM 2026-02-10
Labeling
MIRTAZAPINE 2026-02-02
ESTRADIOL 2026-02-02
ESTRADIOL 2026-01-22
Labeling
ESTRADIOL 2025-12-08
FLUPHENAZINE HYDROCHLORIDE 2025-11-18
DEXTROAMPHETAMINE SULFATE 2025-10-28
Manufacturing (CMC)
MIRTAZAPINE 2025-10-02
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 33%
1 drugs
Respiratory 33%
1 drugs
Dermatology 33%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Oncology, Dermatology
Novartis big-pharma
Oncology, Respiratory
Baxter specialty
Oncology, Dermatology
OTSUKA big-pharma
Dermatology, Oncology, Respiratory
GSK big-pharma
Respiratory, Oncology